Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcomeric protein mutations in dilated cardiomyopathy.

Audrey N Chang1, James D Potter

  • 1Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA.

Heart Failure Reviews
|January 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WNK1 Kinase Activity Is Required for the Functional Maintenance of Podocyte Structure.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

WNK1 kinase activity is required for maintenance of podocyte foot process structure.

bioRxiv : the preprint server for biology·2025
Same author

Calcium-sensing receptor- and ADAM10-mediated klotho shedding is regulated by tetraspanin 5.

FEBS letters·2025
Same author

Glomerular Elasticity and Gene Expression Patterns Define Two Phases of Alport Nephropathy.

bioRxiv : the preprint server for biology·2024
Same author

The MYPT2-regulated striated muscle-specific myosin light chain phosphatase limits cardiac myosin phosphorylation in vivo.

The Journal of biological chemistry·2024
Same author

Myosin light chain phosphatase catalytic subunit dephosphorylates cardiac myosin via mechanisms dependent and independent of the MYPT regulatory subunits.

The Journal of biological chemistry·2022

Dilated cardiomyopathy (DCM) is linked to mutations in sarcomere and cytoskeleton proteins. This review summarizes these DCM-associated mutations and their functional effects on cardiac muscle structure and function.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Genetic factors play a crucial role in the pathogenesis of DCM.
  • Mutations in sarcomere and cytoskeleton proteins are increasingly recognized as key contributors to DCM.

Purpose of the Study:

  • To review and summarize known mutations in sarcomere and cytoskeleton proteins associated with DCM.
  • To discuss the functional consequences of these mutations based on available studies.
  • To explore the relationship between mutation effects and protein structure.

Main Methods:

  • Literature review of studies reporting DCM-associated mutations.
  • Analysis of functional studies investigating the impact of identified mutations.

Related Experiment Videos

  • Correlation of mutation effects with the structural context of affected proteins.

    • Main Results:

    • Identified mutations in key sarcomere proteins including beta-myosin heavy chain (beta-MHC), myosin binding protein-C (MyBP-C), actin, alpha- tropomyosin (Tm), troponin T (TnT), troponin I (TnI), and troponin C (TnC).
    • Reviewed mutations in cytoskeletal proteins such as titin, T-cap, desmin, vinculin, and muscle LIM protein (MLP).
    • Highlighted the diverse effects of these mutations on protein function and cardiac muscle mechanics.

    Conclusions:

    • A wide spectrum of mutations in sarcomere and cytoskeleton proteins are associated with DCM.
    • The precise mechanisms by which these mutations lead to DCM remain incompletely understood.
    • Shared pathogenic mechanisms may underlie DCM caused by mutations in diverse cardiac structural proteins.